Novavax Push For COVID-19 Vaccine Manufacturing Capacity Delays Flu Vaccine Application

 
• By Sarah Karlin-Smith
  
Syringe vaccine and vaccine production. Mass-produced syringes with the vaccine contained in it. The new syringes are labelled with the word “vaccine” and the needles have a grey safety lid on them.
Novavax CEO Stanley Erck discussed his company's vaccine portfolio 10 September
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Vaccines

More from Pink Sheet